Search For "drug candidates"
Study suggests antibody therapy can be used to treat liver disease
Updated : 3 years, 1 month ago IST
There is currently no medication available to treat non-alcoholic liver disease, which affects many type 2 diabetes patients and can develop into more serious liver ailments. A therapeutic option for the treatment of fatty liver has been identified in a study led by Karolinska Institute rese
Read More
Study reveals antibody therapy for treating liver disease
Updated : 3 years, 1 month ago IST
There is presently no medication available to treat non-alcoholic fatty liver disease, which affects many patients with type 2 diabetes and can lead to other serious liver illnesses. A therapeutic candidate for the treatment of fatty liver has been identified in a study headed by Karolinska
Read More
Genetic mechanism hijacked by COVID also makes it vulnerable to new class
Updated : 4 years, 8 months ago IST
Washington [US] June 24 (ANI): During a new study, researchers found a human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help it spread, which also makes it vulnerable to a new class of drug candidates.
Read More
Study shows these Alzheimer's drug candidates reverse broader ageing
Updated : 6 years, 2 months ago IST
Washington D.C. [USA], Dec 15 (ANI): A new study suggests that the Alzheimer's drug candidates CMS121 and J147 may be useful for treating a broader array of conditions and points out a new pathway that links normal ageing to Alzheimer's disease.
Read More
Underwater forest a store of potential new drugs, shows study
Updated : 6 years, 11 months ago IST
Washington D.C. [USA], Apr 9 (ANI): For the first time, a new study has revealed that a common species of seaweed, Laminaria Ochroleuca, is a rich source of bacteria with antimicrobial and anticancer activities - and potential new drug candidates.
Read More
Here's cancer immunotherapy solution to bring novel immuno-oncology d
Updated : 8 years, 6 months ago IST
New Delhi [India], July 24 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
Read More
TRAC, Canada and MedGenome announce Cancer Immunotherapy solution to bring
Updated : 8 years, 6 months ago IST
New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
Read More
TRAC, MedGenome announce Cancer Immunotherapy solution
Updated : 8 years, 6 months ago IST
New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.
Read More